Detalhe da pesquisa
1.
Dysregulation of early gene response to a mixed meal in skeletal muscle in obesity and type 2 diabetes.
Physiol Genomics
; 55(10): 468-477, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545425
2.
HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study.
Diabetes Obes Metab
; 25(7): 1890-1899, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906837
3.
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Diabetes Obes Metab
; 25(1): 46-55, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111434
4.
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Am Heart J
; 243: 232-239, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34666013
5.
Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study.
Diabetes Obes Metab
; 24(9): 1734-1740, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35546275
6.
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study.
Diabetes Obes Metab
; 23(10): 2336-2343, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34212481
7.
Associations between second-line glucose-lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose-lowering treatment intensification: The DISCOVER study.
Diabetes Obes Metab
; 23(8): 1823-1833, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852202
8.
Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study.
Diabetes Obes Metab
; 23(8): 1956-1960, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852196
9.
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study.
Diabetes Obes Metab
; 23(1): 39-48, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32845558
10.
Direct Effect of the Synthetic Analogue of Glucagon-Like Peptide Type 1, Liraglutide, on Mature Adipocytes Is Realized through Adenylate-Cyclase-Dependent Enhancing of Insulin Sensitivity.
Biochemistry (Mosc)
; 86(3): 350-360, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33838634
11.
AICAR Protects Vascular Endothelial Cells from Oxidative Injury Induced by the Long-Term Palmitate Excess.
Int J Mol Sci
; 23(1)2021 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008640
12.
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme.
Diabetes Obes Metab
; 22(1): 66-78, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31468637
13.
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme.
Diabetes Obes Metab
; 21(11): 2474-2485, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31297947
14.
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
Cardiovasc Diabetol
; 17(1): 150, 2018 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30486889
15.
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.
Diabetes Obes Metab
; 20(2): 427-437, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28834075
16.
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.
Diabetes Obes Metab
; 20(2): 389-399, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28817227
17.
Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG).
Cardiovasc Diabetol
; 16(1): 137, 2017 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061170
18.
Regulation of Adipose Tissue Stem Cells Angiogenic Potential by Tumor Necrosis Factor-Alpha.
J Cell Biochem
; 117(1): 180-96, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26096299
19.
Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2.
J Transl Med
; 12: 337, 2014 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25491476
20.
Application of Clinical Blood Metabogram to Type 2 Diabetes Mellitus.
Metabolites
; 14(3)2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38535328